Similar Articles
The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1040
Issue: 2023, Volume 4 - Issue 1
284
326
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
240
281
Nasopharyngeal Carcinoma: Causes and Incidence
Fatih Özgür Sarıbıyık, Oytun Erbaş
DOI: 10.5606/jebms.2023.1060
Issue: 2023, Volume 4 - Issue 3
155
139
The Influence of Socioeconomic Status on Pregnancy Characteristics and Type 2 Diabetes
Hilal Özgül, Orhan Sadık Kızılyalın, Oytun Erbaş
DOI: 10.5606/jebms.2023.1062
Issue: 2023, Volume 4 - Issue 3
86
129
Regulatory T Cells and Their Implications in Cancer Immunotherapy
Saime Sıla Gemici, Oytun Erbaş
DOI: 10.5606/jebms.2023.1064
Issue: 2023, Volume 4 - Issue 3
128
153
Stem Cell Therapy for Diabetes Treatment
Aslı Melike Ekmekçi, Mai Abusalim, Oytun Erbaş
DOI: 10.5606/jebms.2024.1074
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
60
94
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
66
107
Stem Cell Therapy in Cancer
Ayça Nur Demir, Oytun Erbaş
DOI: 10.5606/jebms.2024.1084
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
79
99